Abbonarsi

Basic research on curcumin in cervical cancer: Progress and perspectives - 29/04/23

Doi : 10.1016/j.biopha.2023.114590 
Xiaoyu Zhang a, Lin Zhu a, Xuezhen Wang a, Hairong Zhang b, Lianzhong Wang c, , Lei Xia d,
a School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China 
b Department of Obstetrics and Gynecology, Shandong Provincial Third Hospital, Jinan, China 
c Department of Respiratory and Critical Care Medicine of Second affiliated hospital, Shandong University of Traditional Chinese Medicine, Jinan, China 
d Department of Pathology, Shandong University of Traditional Chinese Medicine, Jinan, China 

Correspondence to: Second affiliated hospital, Shandong University of Traditional Chinese Medicine, 250031 Jinan, China.Second affiliated hospital, Shandong University of Traditional Chinese MedicineJinan250031China⁎⁎Correspondence to: Department of pathology, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.Department of pathology, Shandong University of Traditional Chinese MedicineJinan250355China

Abstract

Curcumin is a polyphenolic substance extracted from plants such as Curcuma longa, Curcuma zedoaria, and radix curcumae, and it has attracted much attention because of the anti-inflammatory, antioxidant, anti-tumor, antibacterial and other multiple pharmacological effects. Cervical cancer is one of the most common malignant tumors in women. With the application of HPV (human papillomavirus) vaccine, the incidence of cervical cancer is expected to be reduced, but it remains difficult to promote the vaccine among low-income population. As a commonly used food additive, curcumin has recently been found to have a significant therapeutic effect in the treatment of cervical cancer. In recent years, numerous in vitro and in vivo studies have found that curcumin can have significant efficacy in anti-cervical cancer treatment by promoting apoptosis, inhibiting tumour cell proliferation, metastasis and invasion, inhibiting HPV and inducing autophagy in tumour cells. However, due to poor water solubility, rapid catabolism, and low bioavailability of curcumin, studies on curcumin derivatives and novel formulations are increasing. Curcumin has a wide range of mechanisms of action against cervical cancer and may become a novel antitumor drug in the future, opening up new ideas for the research of curcumin in the field of antitumor. There is a lack of systematic reviews on the mechanism of action of curcumin against cervical cancer. Therefore, this study is a review of the literature based on the mechanism of action of curcumin against cervical cancer, with a view to providing reference information for scientific and clinical practitioners.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : HPV, ROS, COX-2, ER, HCFs, THC., BDMC, ATM, ATR, BRCA1, DNA-PK, MDC1, MGMT, H2A.X, Ras, ERK, iNOS, c-myc, Hsp70, AIF, IRE-1a, ATF6, ASK1, JNK, THC, AKT, HDACs, CDKi, CDK, VEGF, EGFR, HIF-1α, MMP-2, MMP-9, GRB2, Rho A, uPA, NF-κB, AP-1, FRA-1, c-fos, PTPN13, PCNA, TrxR, TGF-β, Pin1, PDT, PS, MRP1, Pgp1, PLGA, PBCA, NOD-SCID, CDF, DDAB, DMSO

Keywords : Curcumin, Cervical cancer, Mechanism, Pathway, Plants


Mappa


© 2023  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 162

Articolo 114590- giugno 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Editorial Board
| Articolo seguente Articolo seguente
  • Puerarin: a potential natural neuroprotective agent for neurological disorders
  • Xue Liu, Rui Huang, Jiye Wan

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.